-
1
-
-
0032824973
-
Signaling defects in T lymphocytes of patients with malignancy
-
Whiteside TL: Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol Immunother 48:346-352, 1999
-
(1999)
Cancer Immunol Immunother
, vol.48
, pp. 346-352
-
-
Whiteside, T.L.1
-
2
-
-
0031722032
-
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy
-
Bukowski RM, Rayman P, Uzzo R, et al: Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy. Clin Cancer Res 4:2337-2347, 1998
-
(1998)
Clin Cancer Res
, vol.4
, pp. 2337-2347
-
-
Bukowski, R.M.1
Rayman, P.2
Uzzo, R.3
-
3
-
-
0033514923
-
Immune surveillance against a solid tumor fails because of immunological ignorance
-
Ochsenbein AF, Klenerman P, Karrer U, et al: Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A 96:2233-2238, 1999
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 2233-2238
-
-
Ochsenbein, A.F.1
Klenerman, P.2
Karrer, U.3
-
4
-
-
0037460116
-
Recognition of pathogen-associated molecular patterns by TLR family
-
Akira S, Hemmi H: Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85-95, 2003
-
(2003)
Immunol Lett
, vol.85
, pp. 85-95
-
-
Akira, S.1
Hemmi, H.2
-
5
-
-
1642362512
-
Combined TLR and CD40 triggering induces potent CD8+ T-cell expansion with variable dependence on type I IFN
-
Ahonen CL, Doxsee CL, McGurran SM, et al: Combined TLR and CD40 triggering induces potent CD8+ T-cell expansion with variable dependence on type I IFN. J Exp Med 199:775-784, 2004
-
(2004)
J Exp Med
, vol.199
, pp. 775-784
-
-
Ahonen, C.L.1
Doxsee, C.L.2
McGurran, S.M.3
-
6
-
-
0028311276
-
Combination cytokine therapy in cancer
-
Goldfarb RH, Whiteside TL eds, New York, NY, Marcel Dekker
-
Ernstoff MS: Combination cytokine therapy in cancer, in Goldfarb RH, Whiteside TL (eds): Tumor Immunology and Cancer Therapy. New York, NY, Marcel Dekker, 1994, pp 273-279
-
(1994)
Tumor Immunology and Cancer Therapy
, pp. 273-279
-
-
Ernstoff, M.S.1
-
8
-
-
0242575283
-
Tumor immunity meets autoimmunity: Antigen levels and dendritic cell maturation
-
Spiotto MT, Fu YX, Schreiber H: Tumor immunity meets autoimmunity: Antigen levels and dendritic cell maturation. Curr Opin Immunol 15:725-730, 2003
-
(2003)
Curr Opin Immunol
, vol.15
, pp. 725-730
-
-
Spiotto, M.T.1
Fu, Y.X.2
Schreiber, H.3
-
10
-
-
24944459890
-
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
-
Attia P, Phan GQ, Maker AJ, et al: Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 23:6043-6053, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 6043-6053
-
-
Attia, P.1
Phan, G.Q.2
Maker, A.J.3
-
11
-
-
0023888654
-
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells
-
Atkins MB, Mier JW, Parkinson DR, et al: Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 318:1557-1563, 1988
-
(1988)
N Engl J Med
, vol.318
, pp. 1557-1563
-
-
Atkins, M.B.1
Mier, J.W.2
Parkinson, D.R.3
-
12
-
-
0034606276
-
Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of t cell-mediated vitiligo
-
Yee C, Thompson JA, Roche P, et al: Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of t cell-mediated vitiligo. J Exp Med 192:1637-1644, 2000
-
(2000)
J Exp Med
, vol.192
, pp. 1637-1644
-
-
Yee, C.1
Thompson, J.A.2
Roche, P.3
-
13
-
-
0031890206
-
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
-
Rosenberg SA, Yang JC, Schwartzentruber DJ, et al: Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4:321-327, 1998
-
(1998)
Nat Med
, vol.4
, pp. 321-327
-
-
Rosenberg, S.A.1
Yang, J.C.2
Schwartzentruber, D.J.3
-
14
-
-
0032523943
-
Expression of Fas(APO-1/CD95) in tumor infiltrating and peripheral blood lymphocytes in patients with renal call carcinoma
-
Cardi G, Heaney JA, Schned AR: Expression of Fas(APO-1/CD95) in tumor infiltrating and peripheral blood lymphocytes in patients with renal call carcinoma. Cancer Res 58:2078-2080, 1998
-
(1998)
Cancer Res
, vol.58
, pp. 2078-2080
-
-
Cardi, G.1
Heaney, J.A.2
Schned, A.R.3
|